RIGEL PHARMACEUTICALS has a total of 17 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Brazil, Poland and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are TIAN JIN TASLY GROUP CO LTD, IVASHCHENKO ANDREJ ALEKSANDROV and APOGLYX AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | Brazil | 3 | |
#2 | Poland | 3 | |
#3 | United States | 3 | |
#4 | Croatia | 2 | |
#5 | Cuba | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Serbia | 1 | |
#8 | Singapore | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Measurement | |
#5 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Singh Rajinder | 13 |
#2 | Argade Ankush | 6 |
#3 | Clough Jeffrey | 6 |
#4 | Payan Donald G | 6 |
#5 | Keim Holger | 6 |
#6 | Goff Dane | 6 |
#7 | Sylvain Catherine | 6 |
#8 | Li Hui | 6 |
#9 | Bhamidipati Somasekhar | 6 |
#10 | Partridge John | 5 |
Publication | Filing date | Title |
---|---|---|
US7220745B2 | Heterocyclic compounds useful to treat HCV | |
US2003195138A1 | BAP-1: methods of assaying for cell-cycle modulators |